Compositions and methods for prevention and treatment of uncontrolled
formation of intravascular fibrin clots, which are capable of selective dissolution
of pathological nascent clots formed intravascularly, with minimal risk of unwanted
dissolution of pre-existing hemostatic clots, are provided wherein fibrinolytic
or anticoagulant drugs are biocompatibly coupled to red blood cell carriers.